A bacteriocin-based treatment option for Staphylococcus haemolyticus biofilms
Abstract Bacteriocins are ribosomally-synthesized antimicrobial peptides, showing great potential as novel treatment options for multidrug-resistant pathogens. In this study, we designed a novel hybrid bacteriocin, Hybrid 1 (H1), by combing the N-terminal part and the C-terminal part of the related...
Guardado en:
Autores principales: | Christian Kranjec, Sofie S. Kristensen, Karolina T. Bartkiewicz, Mikkel Brønner, Jorunn P. Cavanagh, Aparna Srikantam, Geir Mathiesen, Dzung B. Diep |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4bb49ca80ceb456895b33b7ca266dcc3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pathogenesis of Staphylococcus haemolyticus on primary human skin fibroblast cells
por: Hala O. Eltwisy, et al.
Publicado: (2020) -
The Non-Lantibiotic Bacteriocin Garvicin Q Targets Man-PTS in a Broad Spectrum of Sensitive Bacterial Genera
por: Aleksandra Tymoszewska, et al.
Publicado: (2017) -
Distribution of Staphylococcus haemolyticus as the most dominant species among Staphylococcal infections at the Zainoel Abidin Hospital in Aceh, Indonesia
por: SUHARTONO, et al.
Publicado: (2019) -
Comprehensive analysis of bacteriocins in Streptococcus mutans
por: Atsuko Watanabe, et al.
Publicado: (2021) -
Bacteriocin-mediated inhibition of some common pathogens by wild and mutant Lactobacillus species and in vitro amplification of bacteriocin encoding genes
por: Arooj Ahsan, et al.
Publicado: (2021)